In this study, we identified IκBα as a PPI partner protein of AURKC, as well as a small-molecule inhibitor that targets the AURKC–IκBα interaction and interferes with the growth and tumorigenic activity of breast cancer cells. The gene discussed is NFKBIA; the disease is breast carcinoma.